DaVita (DVA) Tops Q2 EPS by 8c
Tweet
Share
E-mail
Get Alerts DVA Hot Sheet
Price: $181.33 -0.92%
EPS Growth %: +43.8%
Financial Fact:
Patient care costs: 2.7B
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +43.8%
Financial Fact:
Patient care costs: 2.7B
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
DaVita (NYSE: DVA) reported Q2 EPS of $1.05, $0.08 better than the analyst estimate of $0.97. Revenue for the quarter came in at $2.89 billion versus the consensus estimate of $2.88 billion.
For earnings history and earnings-related data on DaVita (DVA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- Frequency Electronics (FEIM) Tops Q1 EPS by 12c
- Lightpath Technologies (LPTH) Misses Q4 EPS by 5c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
